Estimation of Drug Cost Avoidance and Pathology Cost Avoidance Through Participation in NCIC Clinical Trials Group Phase III Clinical Trials in Canada
Current Oncology（2016）
Key words
Cost avoidance,phase III trials
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined